Feb 20, 2026 10:57AM
Feb 20, 2026 10:57AM
Jan 14, 2026 08:49AM
Dec 2, 2025 08:01AM
Dec 2, 2025 08:00AM
Oct 22, 2025 12:00PM
May 9, 2025 02:53PM Dr. Reddy’s Q4 & Full Year FY25 Financial Results
Mar 13, 2025 10:40AM
Aug 20, 2024 02:53PM
Aug 20, 2024 02:42PM
Jul 27, 2024 09:51AM
May 7, 2024 10:31AM
May 3, 2024 08:00AM
Jan 31, 2024 09:44AM Dr. Reddy’s Q3 & 9M FY24 Financial Results
Dec 6, 2023 07:01AM
Dec 6, 2023 07:00AM
Jul 12, 2023 10:25AM
Jan 27, 2023 07:03AM
Jul 27, 2022 03:26AM
Jul 22, 2022 06:17AM
Jul 8, 2022 11:51AM Dr. Reddys Labs (RDY) Announces Launch of Fesoterodine Fumarate Extended-Release Tablets in the U.S. Market
Jul 8, 2022 11:48AM
Jun 14, 2022 02:51AM
May 27, 2022 10:15AM
May 24, 2022 01:40PM
Apr 20, 2022 12:41PM
Apr 5, 2022 06:52AM
Feb 9, 2022 09:17AM Dr. Reddy's Laboratories Announces the Launch of Its Authorized Generic Version of VASOSTRICT® (vasopressin injection, USP) Vials in the U.S. Market
Dec 9, 2021 11:47PM
Dec 9, 2021 03:18AM
Dec 9, 2021 12:50AM
Dec 8, 2021 09:00PM
Oct 29, 2021 08:59AM
Oct 19, 2021 12:14AM
Oct 15, 2021 01:40PM Dr. Reddy's Laboratories Announces the Launch of Carmustine for Injection, USP in the U.S. Market
Aug 31, 2021 02:43AM
Aug 4, 2021 10:32AM
Aug 3, 2021 08:32AM
Jun 22, 2021 02:07AM
May 12, 2021 12:56AM
Apr 29, 2021 10:41AM
Apr 7, 2021 04:56AM Dr. Reddy's Laboratories Announces the Launch of a Generic Version of Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg in the U.S. Market
Feb 22, 2021 01:13AM
Feb 18, 2021 01:50AM
Feb 17, 2021 05:11AM
Feb 2, 2021 04:20AM
Jan 11, 2021 04:59AM
Nov 12, 2020 10:47AM
Oct 20, 2020 03:44AM Dr. Reddy’s announces the re-launch of over-the-counter Famotidine Tablets USP, 10 mg and 20 mg, store-brand equivalent of Pepcid AC® in the U.S. Market
Oct 1, 2020 04:08AM

322,969 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All